Mide-400 (2026)

Often used in oncology regimens or for treating systemic conditions like retinal vasculitis or stage IV ovarian cystadenocarcinoma.

MIDE-400 is considered part of the "leaked" or "uncensored" sub-genre that surfaced around the time of its release, making it popular among fans of the label. As a 2017 release from a major studio like MoodyZ, it fits into a mature phase of schoolgirl-themed digital content, often featuring high-definition (FHD) production quality. mide-400

Released in early 2017, is a notable title within the niche "schoolgirl" genre of JAV (Japanese Adult Video). Produced by the well-known studio MoodyZ, this production focuses on a dramatic transfer student scenario. Production and Release Details DVD ID: MIDE-400 Release Date: February 10, 2017 Studio: MOODYZ Label: MIDE Director: Usami Tadanori Runtime: Approximately 179 minutes Plot and Genre Often used in oncology regimens or for treating

Note: This article is based on publicly available JAV catalog information and user reviews. Released in early 2017, is a notable title

For collectors or viewers of the genre, MIDE-400 is often remembered as a representative work from Takahashi's active years, showcasing the high production values characteristic of the MOODYZ label. It serves as a notable entry in the filmography of one of the most recognizable actresses of that era.

The most prominent technical use of "mide 400" refers to standardized 400 mg dosages of various medicines, particularly in neurology and oncology.